Contact

location_on

2 rue du Cristal
45520 Chevilly
France

Ludovic Landemarre
Directeur

About us

GLYcoDiag is a research and development company specialized in glycosciences which provides services and products for the fields of health (diagnostics, biomarkers, therapeutic recombinant glycoproteins, vaccines), cosmetics (active ingredients, design and mechanisms of “glyco-actives”) and environment (biofilms, waste water).

Business offer

Thanks to a complete proprietary technology plateform GLYcoPROFILE® dedicated to the study of glycosylation interactions combined with a long expertise in this field, allows GLYcoDiag to offer a complete range of services: - Use of glycans signature of your therapeutic recombinant glycoproteins (screening and selection of clones, batch to batch monitoring, biosimilar vs reference profile, glycoforms specific profiles, immunogen glycan detection or in-process monitoring) - Studies of glycome expression. Glyco-biomarkers discovery - Search and characterizenew glycosylated related drugs In addition, GLYcoDiag offers a unique range of reagents and dedicated kits in glycosciences.

Activities

    Categories

    • Service

    Therapeutic applications

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Target selection & validation
    • Research exploratory companion biomarkers
    • Hit discovery
    • Screening & Identification
    • In-vitro & ex-vivo models
    • Immunotherapy lead generation
    • Binding & Affinity
    • Functional effects
    • ADCC, ADCP & CDC
    • Safety
    • Immunogenicity
    • Preclinical biomarkers
    • Mechanism/Function
    • Specificity
    • Research exploratory Companion biomarkers
    • Animal biomarkers
    • Human biomarkers
    • Predictive biomarkers
    • Treatment efficacy
    • Disease progression / follow-up
    • CMC
    • Master Cell Bank
    • Clone selection
    • Characterization
    • Quality assurance, quality control & analytical process
    • Bioproduction analytical test
    • Monitoring
    • Characterization
    • Batch consistency
    • Clinical biomarkers
    • Predictive biomarkers
    • Treatment efficacy
    • Disease progression / follow-up
    • Disease progression monitoring
    • Companion biomarkers
    • Treatment efficacy
    • Treatment monitoring
Français English